VARC-TAVI VALVE IMPLANTATION)
VARC-TAVI
VARC-TAVI (VASCULAR CONTROL in TRANSCATHETER AORTIC VALVE IMPLANTATION)
1 other identifier
interventional
600
0 countries
N/A
Brief Summary
SUMMARY: The investigators are planning a clinical study to compare two methods of performing a procedure called TAVI, used in patients with severe aortic stenosis. In this procedure, the aortic valve is replaced in a less invasive way. Traditionally, access through the groin (femoral) is used, but now radial access (through the wrist) is being considered as an alternative. Reasons for the Study:
- Currently, there is not enough solid evidence to support the choice between these two accesses.
- The investigators want to understand if radial access could be safer and have fewer complications compared to femoral access. What the Investigators Will Measure:
- Major complications, such as bleeding or vascular injuries.
- Other important outcomes, such as functional recovery and quality of life. How the Investigators Will Do It:
- The investigators will randomize patients to receive radial or femoral access.
- The investigators will record which type of access is used and assess complications and outcomes.
- The investigators will compare the results to understand if there are significant differences between the two groups. Ultimate Goal:
- The investigators aim to improve the safety and efficacy of this procedure for patients.
- The results of this study will help doctors make informed decisions on how to perform TAVI. Conclusion: \- This study is crucial for enhancing care for patients with aortic stenosis and ensuring the procedure is performed in the safest and most effective manner. The results will benefit patients and guide doctors in choosing the best approach for each individual.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2023
CompletedFirst Posted
Study publicly available on registry
December 20, 2023
CompletedStudy Start
First participant enrolled
January 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 5, 2024
January 1, 2024
1.7 years
December 11, 2023
January 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ACCESS RELATED OR BLEEDING COMPLICATIONS
Major and minor access-related complications (VARC-3) and major or greater (VARC ≥2) bleeding complications (BARC)
From the enrollment to 4 weeks after the procedure.
Secondary Outcomes (4)
MACE
From the enrollment to 4 weeks after the procedure.
bleeding
From the enrollment to 4 weeks after the procedure.
Quality of life scale
4 weeks after the procedure
Complications not directly TAVI procedure-related
From the enrollment to 4 weeks after the procedure.
Study Arms (2)
RADIAL
EXPERIMENTALRADIAL ARTERY ACCESS AS SECONDARY ACCESS IN TAVI PROCEDURE
FEMORAL
ACTIVE COMPARATORFEMORAL ARTERY ACCESS AS SECONDARY ACCESS IN TAVI PROCEDURE
Interventions
The randomization will determine whether radial or femoral artery puncture will be employed as the secondary access in the TAVI procedure.
Eligibility Criteria
You may qualify if:
- Adult patients with severe aortic stenosis and candidates for transfemoral TAVI.
- Secondary access possible through both radial and femoral routes.
- Capacity to provide informed consent.
You may not qualify if:
- Specific contraindications for radial or femoral access.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor of medicine
Study Record Dates
First Submitted
December 11, 2023
First Posted
December 20, 2023
Study Start
January 8, 2024
Primary Completion
October 1, 2025
Study Completion
December 1, 2025
Last Updated
January 5, 2024
Record last verified: 2024-01